Jiao Xie

1.3k total citations
54 papers, 888 citations indexed

About

Jiao Xie is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Jiao Xie has authored 54 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 24 papers in Pharmacology and 18 papers in Epidemiology. Recurrent topics in Jiao Xie's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antifungal resistance and susceptibility (13 papers) and Antibiotic Resistance in Bacteria (12 papers). Jiao Xie is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Antifungal resistance and susceptibility (13 papers) and Antibiotic Resistance in Bacteria (12 papers). Jiao Xie collaborates with scholars based in China, Australia and France. Jiao Xie's co-authors include Yalin Dong, Haiyan Dong, Taotao Wang, Jianfeng Xing, Yan Wang, Jinyao Sun, Qianting Yang, Xiaowei Zheng, Jason A. Roberts and Xue Wang and has published in prestigious journals such as International Journal of Molecular Sciences, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Jiao Xie

49 papers receiving 876 citations

Peers

Countries citing papers authored by Jiao Xie

Since Specialization

Citations

This map shows the geographic impact of Jiao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Xie more than expected).

Fields of papers citing papers by Jiao Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Xie. The network helps show where Jiao Xie may publish in the future.

Co-authorship network of co-authors of Jiao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Jiao Xie. A scholar is included among the top collaborators of Jiao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiao Xie. Jiao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma 2025 ·Frontiers in Immunology ·Youjia Li, Kai Qu, Xiuli Li, Xin Yang, (unknown), Jiao Xie	0
2	Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia 2024 ·Journal of Pharmaceutical Sciences ·(unknown), Xiuyan Yang, Lu Han, Xi Yang, Jiao Xie, Xiaoqin Liu, (unknown), (unknown), Weiwei Kong, Xiaoying Wu, Yunqing Qiu, Hongfeng Huang, Yan Lou	1
3	Tetrahydrocurcumin Attenuates Polymyxin B Sulfate‐Induced HK ‐2 Cells Apoptosis by Inhibiting Endoplasmic Reticulum Stress‐Mediated PERK / eIF2α / ATF4 / CHOP Signaling Pathway Axis 2024 ·Environmental Toxicology ·Junjie Chen, (unknown), Jing Fan, Jiao Xie, Yan Wang, (unknown), Nengming Lin, Bin Lin	5
4	Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection 2024 ·Drug Design Development and Therapy ·(unknown), (unknown), (unknown), (unknown), Liang Sun, Yuetian Yu, Weibin Fan, Jiao Xie, Bin Lin, Nengming Lin	0
5	Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis 2022 ·Journal of Healthcare Engineering ·Jiao Xie, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study 2022 ·Frontiers in Pharmacology ·Haitao Wang, Haitao Shi, Yan Wang, Na Wang, Youjia Li, Qianting Yang, Ya Li, Chenwei Liu, Ying Zan, (unknown), Jiao Xie	2
7	Population pharmacokinetics of polymyxin B: a systematic review 2022 ·Annals of Translational Medicine ·Na Chen, (unknown), Jiao Xie, (unknown), Hao Xing, (unknown), Yuefeng Rao	13
8	In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method 2022 ·International Journal of Infectious Diseases ·Qianting Yang, (unknown), Yan Wang, Jiao Xie, (unknown), Yalin Dong, Yun F. Wang	4
9	Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations 2020 ·Journal of Antimicrobial Chemotherapy ·Nynke G L Jager, Reinier M. van Hest, Jiao Xie, Gloria Wong, Marta Ulldemolins, Roger J. M. Brüggemann, Jeffrey Lipman, Jason A. Roberts	22
10	Determination of the Solubility, Dissolution Enthalpy, and Entropy of Icariin in Acetone, Acetoacetate, Chloroform, and Light Petroleum 2020 ·Natural Product Communications ·Jiao Xie, (unknown), Haitao Wang, Xin Yang, Wenbin Mao, Chenwei Liu, Na Wang	3
11	Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations 2020 ·International Journal of Antimicrobial Agents ·Jiao Xie, Jason A. Roberts, Jeffrey Lipman, Yan Cai, Haitao Wang, (unknown), (unknown), Shan Yang, Youjia Li, (unknown)	17
12	Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration 2019 ·International Journal of Antimicrobial Agents ·(unknown), Jiao Xie, Gregory Comadira, Brent Richards, Mandy Tallott, Steven C. Wallis, (unknown), Jeffrey Lipman, Jason A. Roberts	2
13	Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy 2018 ·International Journal of Antimicrobial Agents ·(unknown), Jan T. Kielstein, David Czock, Jiao Xie, Jonathan Field, Brent Richards, Mandy Tallott, (unknown), (unknown), Carsten Hafer, Julius J. Schmidt, Jeffrey Lipman, Jason A. Roberts	24
14	Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients 2016 ·International Journal of Antimicrobial Agents ·Haiyan Dong, Jiao Xie, Taotao Wang, Lihong Chen, Xiaoyan Zeng, Jinyao Sun, Xue Wang, Yalin Dong	26
15	Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital 2015 ·American Journal of Infection Control ·Jiao Xie, Yan Wang, Xiaowei Zheng, Qianting Yang, Taotao Wang, (unknown), Jianfeng Xing, Yalin Dong	5
16	Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections 2014 ·International Journal of Antimicrobial Agents ·Taotao Wang, (unknown), Jinyao Sun, Xiaoliang Cheng, Jiao Xie, Haiyan Dong, Limei Chen, Xue Wang, Jianfeng Xing, Yalin Dong	90
17	Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients 2014 ·International Journal of Infectious Diseases ·Haiyan Dong, Jiao Xie, Lihong Chen, Taotao Wang, (unknown), Shihua Zhao, Yalin Dong	16
18	Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis 2014 ·European Journal of Clinical Pharmacology ·Yan Wang, (unknown), Jiao Xie, Taotao Wang, Xiaowei Zheng, Hairong He, Weihua Dong, Jianfeng Xing, Yalin Dong	41
19	Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells 2013 ·Molecular BioSystems ·Siying Chen, Qian Dong, Sasa Hu, Jiangxia Cai, Weipeng Zhang, (unknown), Taotao Wang, Jiao Xie, Hairong He, Jianfeng Xing, Jun Lü, Yalin Dong	25
20	Establishment of Paclitaxel-resistant Breast Cancer Cell Line and Nude Mice Models, and Underlying Multidrug Resistance Mechanisms in Vitro and in Vivo 2013 ·Asian Pacific Journal of Cancer Prevention ·Siying Chen, Sasa Hu, Qian Dong, Jiangxia Cai, Wei-Peng Zhang, (unknown), Taotao Wang, Jiao Xie, Hairong He, Jianfeng Xing, Jun Lü, Yalin Dong	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact